DIAH

DIAH 2026

19 – 21 May 2026 | Bruges, Belgium

Wednesday, 20 May 2026 | 14:45 - 15:30

Masterclass 7: Beyond Monoclonal Antibodies: Next Generation Therapeutics for Animal Health - Multi-specificity for Complex Disease and Other Opportunities

Location:BMCC - 3rd Floor - Turtle RoomTrack:Masterclass

Sign-ups available from 1 Apr 2026, 00:00 to 20 May 2026, 15:30

Beyond Monoclonal Antibodies: Next Generation Therapeutics for Animal Health - Multi-specificity for Complex Disease and Other Opportunities

Monoclonal antibodies have disrupted animal health, significantly impacting the management of conditions with high unmet needs. As their influence grows, this talk explores the next generation of protein therapeutics designed for complex, multi-pathway diseases. Multi-specific proteins are essential to control disease pathology and offer the potential for both symptom relief and disease modification. To remain viable, strategies must achieve multi-specificity without the burden of complex engineering or elaborate manufacturing. Beyond multi-specificity, this session also explores emerging opportunities for protein-based therapeutics and prophylactics.

Charles Owen (272Bio Limited)

1 speaker